Working… Menu
Trial record 2 of 13 for:    ensifentrine

A Phase 3 Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04542057
Recruitment Status : Recruiting
First Posted : September 9, 2020
Last Update Posted : February 26, 2021
Iqvia Pty Ltd
Information provided by (Responsible Party):
Verona Pharma plc

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : January 2022
Estimated Study Completion Date : February 2022